[144] REAL BROKERAGE INC SEC Filing

Rhea-AI Filing Summary

Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 152,000 common shares through RBC Direct Investing with an aggregate market value of $598,880. The notice lists 202,499,045 shares outstanding for the issuer and an approximate sale date of 08/25/2025. The 152,000 shares to be sold trace to specific acquisitions: a private placement of 28,304 shares on 06/20/2020 and restricted stock unit awards dated 01/21/2022, 03/23/2023 and 05/31/2024 totaling the remaining shares.

The filing also discloses recent dispositions by Matchpoint Capital Inc., which sold 50,000 common shares on 06/23/2025 for combined gross proceeds of $200,264.20. The filer affirms there is no undisclosed material adverse information and provides broker, acquisition, and past-sale details to document the proposed transaction.

Positive

• Full disclosure of the 152,000 shares' provenance (private placement plus RSUs) supports traceability
• Broker and aggregate market value are provided (RBC Direct Investing; $598,880), aiding transparency

Negative

• Insider/affiliate sales of 50,000 shares occurred within the past three months, generating $200,264.20 in proceeds
• Planned sale of 152,000 shares will increase float available for trading, which may modestly affect supply

Insights

Securities Analyst

Form 144 shows a planned sale of 152,000 REAX shares; recent insider sales totaled 50,000 shares for $200,264.

The filing details a proposed disposition of 152,000 common shares with a stated aggregate market value of $598,880, to be executed through RBC Direct Investing. The acquisition table identifies the lot origins—one private placement and multiple RSU grants—which account for the 152,000 shares disclosed for sale. Recent activity by Matchpoint Capital shows 50,000 shares sold on 06/23/2025 for total proceeds of $200,264.20, which the filing lists under securities sold in the past three months. From a market-impact perspective, the filing provides clear traceability of the shares and the broker used.

Corporate Governance Expert

Disclosure is complete on lot provenance and recent sales; the filer attests to no undisclosed material adverse information.

The Form 144 includes detailed source information for the securities to be sold—distinguishing private placement shares and RSU-originated shares—which supports compliance with Rule 144 documentation requirements. The filing also contains the customary representation that no material nonpublic information exists. Matchpoint Capital's sale of 50,000 shares in the prior three months is explicitly reported, improving transparency around insider/affiliate transactions. Overall, the submission is procedurally thorough and auditable from a governance standpoint.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	RBC Direct Investing Royal Bank Plaza, 200 Bay Street North Tower, P.O. Box 75 Toronto A6 M5J 2Z5	152000	598880.00	202499045	08/25/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2020	Acquired through private placement in connection with a business combination	Issuer			28304	06/20/2020	Cash
Common	05/31/2024	RSU	Issuer			21844	05/31/2024	N/A
Common	03/23/2023	RSU	Issuer			60000	03/23/2023	N/A
Common	05/31/2024	RSU	Issuer			9101	05/31/2024	N/A
Common	01/21/2022	RSU	Issuer			32751	01/21/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	5000	19900.00
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	12000	48000.00
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	5000	20000.50
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	3000	12007.20
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	10000	40100.00
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	5000	20055.50
Matchpoint Capital Inc. 25 York Street Suite 612 Toronto A6 M5J 2V5	Common	06/23/2025	10000	40201.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does REAX's Form 144 report?

The filing reports a proposed sale of 152,000 common shares with an aggregate market value of $598,880 via RBC Direct Investing.

When is the proposed REAX sale expected to occur?

The Form 144 lists an approximate date of sale of 08/25/2025.

How many REAX shares are outstanding according to the filing?

The filing indicates 202,499,045 shares outstanding.

What is the origin of the 152,000 shares to be sold?

They were acquired via a private placement (28,304 shares on 06/20/2020) and several RSU grants on 01/21/2022, 03/23/2023, and 05/31/2024.

Has the filer sold any REAX shares recently?

Yes. Matchpoint Capital Inc. sold 50,000 shares on 06/23/2025, yielding total gross proceeds of $200,264.20.